Brand / product

MEGAFLOX

Ciprofloxacin · 2 mg

₨ Official source-observed price PKR 264.04 100ml

PKR 2.64 / mL

✓ Official DRAP price source observed · Source checked 2026-10-09

Price Intelligence

Equivalent price position

Same generic · strength · dosage form · compatible unitPrice Intelligence PRO →

This brandPKR 2.64/ mL

Price position29% above medianvs like-for-like peer median

Peer comparators1current-price listings

🔒

MedInfoBase Pharma Pro

Unlock the full competitive price benchmark

See the exact peer median, min/max and quartiles, product rank, price percentile and the complete like-for-like competitor table.

Rank & percentilePeer medianFull competitor listPortfolio intelligence

View Price Intelligence PRO

Price-position comparison uses current official listed prices normalized to compatible units. It is a price benchmark, not a measure of sales, demand, prescription volume or market share.

Product details

Generic: Ciprofloxacin
Therapeutic area: Anti-infectives
Drug class: Fluoroquinolone antibacterials
ATC: J01MA
Strength: 2 mg
Dosage form: IV infusion
Pack: 100ml
Registration no.: 037378
Price record verified: 2026-08-08
Latest DRAP source check: 2026-10-09 03:22

Manufacturer

Geofman Pharmaceuticals

Explore this manufacturer's complete MedInfoBase portfolio, generics and current listed prices.

View company portfolio →

Summary

About MEGAFLOX 2 mg IV infusion

MEGAFLOX 2 mg IV infusion contains Ciprofloxacin 2 mg. It is registered with DRAP by Geofman Pharmaceuticals (registration no. 037378). Its official price is PKR 264.04 for a pack of 100ml. This price has applied since 23 July 2026. MEGAFLOX is also available as 250 mg tablet and 500 mg tablet. 1 other brand of Ciprofloxacin 2 mg (IV infusion) is registered in Pakistan. Compare all brands and prices →

Same brand

Other strengths of MEGAFLOX

MEGAFLOX 250 mgTablet · 10's · PKR 350.01 MEGAFLOX 500 mgTablet · 10's · PKR 616.01

Same medicine and strength

Other brands of Ciprofloxacin 2 mg

Piprocap 2 mgNimrall Laboratories · PKR 204.13 / 100ml

Price movement

Official price over time

No change in the official DRAP price is recorded for this pack (100ml). Current price PKR 264.04, effective 23 Jul 2026.

Cite this price history

MedInfoBase. MEGAFLOX 2 mg, 100ml: official price history (source: DRAP PharmaPrice Index). https://medinfobase.com/brand/megaflox-2-mg-037378-100ml-geofman-pharmaceuticals/ (accessed 9 October 2026).

Traceability

Official price history

Amount	Effective from	Verified	Source	Status
PKR 264.04	2026-07-23	2026-08-08	DRAP PharmaPrice Index	Current

Same generic

Other listed brands

A-CIP 400 mg/100 mLAllmed (Pvt.) Ltd · PKR 340.78 A-CIP 200 mg/100 mLAllmed (Pvt.) Ltd · PKR 247.84 A-CIP 500 mgAllmed (Pvt.) Ltd · PKR 444.03 A-CIP 250 mgAllmed (Pvt.) Ltd · PKR 268.49 ADACIP 250 mgAdamjee Pharmaceuticals (Pvt) Ltd · PKR 346.16 ADACIP 500 mgAdamjee Pharmaceuticals (Pvt) Ltd · PKR 610.86 ADACIP 750 mgAdamjee Pharmaceuticals (Pvt) Ltd · PKR 356.79 ADACIP 250 mg/5 mLAdamjee Pharmaceuticals (Pvt) Ltd · PKR 325.79

Evidence note: “Source observed” means MedInfoBase captured the record from an official DRAP source; it does not by itself mean the product registration was independently matched in the DRAP registry. Price note: Unit-price comparisons are informational calculations from official-source pack prices and normalized pack quantities. A pharmacy's transaction price may differ. Verify current regulatory and product information before professional use.

Cite this record

Medicine record · DRAP registration 037378

MedInfoBase. (2026). MEGAFLOX 2 mg IV infusion (100ml), Geofman Pharmaceuticals — registration and price record [Data set]. MedInfoBase. Retrieved October 9, 2026, from https://medinfobase.com/brand/megaflox-2-mg-037378-100ml-geofman-pharmaceuticals/ Data observed 8 August 2026. Source: DRAP PharmaPrice Index. DRAP registration 037378.

Download .RIS Download .BIB EndNote, Zotero, Mendeley, RefWorks

Price and registration data on this page were observed on 8 August 2026. Records change over time, so please cite the observation date alongside the access date.